Hotopf, Max

 

What we Learned at HBI 2022

What are the main insights and learnings from HBI 2022?  Martin Henrichs of UBS and Max Hotopf, HBI founder, talks about the key takeaways this year in terms of new business models, sector and regional insights, digital impact and the investment climate. Martin Henrichs, Managing Director, Healthcare, UBS Max Hotopf, Founder & Chairman, Healthcare Business […]

The Truth about AI

Has AI delivered for healthcare – yet? In this session we’ll explore what we know about AI today and how we can best shape our thinking about AI as a tool in the transformation toolkit. Through case studies we’ll look at scenarios where AI is delivering impact, providing a deep-dive into the practicalities of implementation. […]

Rehabilitation

The case for rehabilitation is strong, but not always realised. But is the sector set to grow thanks to an increasing focus on outcomes, wellness and population health? Our panel of experts will assess this fragmented marketplace, shortlist the most attractive business models whether digital, outpatient or inpatient and assess in which countries there is […]

Digitalising Patient Care, the State of Play

The pandemic forced a sharp uptick in digitising patient care, but as we settle into the new normal we take an in-depth look at examples of how digital transformation has reached a new horizon. How is data being used to develop patient pathways and new models of care?  What do we know about the changing […]

Regulatory & Political Risk

This remains the number one issue for investors and operators in most countries, second only to “how do I get staff?” as something liable to keep CEOs awake at night. Here we look in detail at what risks there are in different countries and sectors. what, if anything, can the sector do to allay them? […]

Investing in Europe

What do investors think about key sectors and valuations in Europe? How are concerns about increasing inflation rates impacting valuations? What impact are the ongoing healthcare reforms in the wake of the pandemic having on investment? Speakers include: Martin Henrichs, Managing Director – Head of Healthcare EMEA, UBS Anja Bickelmaier, Co Head of Healthcare, Triton […]

HBI Wrap-up session – In conversation with Martin Henrichs, UBS

What are the main insights and learnings from HBI 2021?  Max Hotopf, HBI founder talks to Martin Henrichs about what they both take away from the conference this year in terms of new business models, sector and regional insights, digital impact and the investment climate.

The New Covid-19 Policymaking Landscape

Healthcare has become far more important politically. So governments have become far more proactive and big data sets enable them, often for the first time, to systematically target vulnerable groups with high rates of co-morbidity with new programmes. What are the implications of these revolutionary changes? Confirmed speakers include: Markus Siebert, Abbott Martin Brunninger, Department […]

Funding and Recovery

The pandemic has seen governments redefine their relationship with the for-profit sector. Sometimes it is viewed as a valuable partner, sometimes as a parasite to be controlled and partly nationalised. This session explores what has changed and how the private sector has reacted to these pressures. What are the implications of this new relationship? Confirmed […]

Diagnostics: Sector Analysis

Covid-19 massively boosted lab revenues. But will labs retain the special relationship they have built with governments?  US groups, for instance, are monetising their data by working with payors on disease prevention. How are labs using digital to help doctors interpret results and to reach the consumer? Confirmed speakers include: Michiel Boehmer, Unilabs Evangelos Kotsopoulos, […]

Find Us